Agency Information Collection Activities; Submission for OMB Review; Comment Request; Job Clubs Study, 15975 [2013-05775]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 49 / Wednesday, March 13, 2013 / Notices
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46, all applicants for
registration to import a basic class of
any controlled substances in schedules
I or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: March 7, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on DSK4VPTVN1PROD with NOTICES
Importer of Controlled Substances,
Notice of Registration: Hospira Inc.
By Notice dated December 14, 2012,
and published in the Federal Register
on December 21, 2012, 77 FR 75670,
Hospira Inc., 1776 North Centennial
Drive, McPherson, Kansas 67460–1247,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Remifentanil (9739), a basic class of
controlled substance listed in schedule
II.
The company plans to import
Remifentanil for use in dosage form
manufacturing.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Hospira Inc. to import the basic class of
controlled substance is consistent with
the public interest, and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
has investigated Hospira Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
17:11 Mar 12, 2013
Jkt 229001
Dated: March 7, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–05794 Filed 3–12–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances, Notice of Registration;
Johnson Matthey, Inc.,
Pharmaceuticals Materials
By Notice dated November 1, 2012,
and published in the Federal Register
on November 9, 2012, 77 FR 67397,
Johnson Matthey, Inc., Pharmaceuticals
Materials, 900 River Road,
Conshohocken, Pennsylvania 19428,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
[FR Doc. 2013–05793 Filed 3–12–13; 8:45 am]
VerDate Mar<15>2010
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Drug
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Codeine (9050) .............................
Oxycodone (9143) ........................
Diphenoxylate (9170) ...................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Thebaine (9333) ...........................
I
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its
customers.
The Thebaine (9333) will also be used
to manufacture other controlled
substances for sale in bulk to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Inc., Pharmaceuticals
Materials to manufacture the listed basic
classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Johnson
Matthey Inc., Pharmaceuticals Materials
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
PO 00000
Frm 00048
Fmt 4703
Sfmt 9990
15975
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: February 27, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–05799 Filed 3–12–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Job Clubs
Study
ACTION:
Notice; correction.
The Department of Labor
published a document in the Federal
Register of February 26, 2013,
concerning request for comments on site
visits to job clubs. The document
contained incorrect dates.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Contact Ben Seigel by telephone at 202–
693–6032 (this is not a toll-free number)
or by email at CFBNP@dol.gov.
Correction
In the Federal Register of February
26, 2013, in FR Doc. 2013–04391, on
page 13086, in the second column,
correct the DATES caption to read:
Written comments must be
submitted to the office listed in the
addressee section on or before April 27,
2013.
DATES:
Signed at Washington, DC, this 5th day of
March, 2013.
Irasema Garza,
Acting Assistant Secretary for Policy, U.S.
Department of Labor .
[FR Doc. 2013–05775 Filed 3–12–13; 8:45 am]
BILLING CODE P
E:\FR\FM\13MRN1.SGM
13MRN1
]]>Agencies
[Federal Register Volume 78, Number 49 (Wednesday, March 13, 2013)]
[Notices]
[Page 15975]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05775]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection Activities; Submission for OMB
Review; Comment Request; Job Clubs Study
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Department of Labor published a document in the Federal
Register of February 26, 2013, concerning request for comments on site
visits to job clubs. The document contained incorrect dates.
FOR FURTHER INFORMATION CONTACT: Contact Ben Seigel by telephone at
202-693-6032 (this is not a toll-free number) or by email at
CFBNP@dol.gov.
Correction
In the Federal Register of February 26, 2013, in FR Doc. 2013-
04391, on page 13086, in the second column, correct the DATES caption
to read:
DATES: Written comments must be submitted to the office listed in the
addressee section on or before April 27, 2013.
Signed at Washington, DC, this 5th day of March, 2013.
Irasema Garza,
Acting Assistant Secretary for Policy, U.S. Department of Labor .
[FR Doc. 2013-05775 Filed 3-12-13; 8:45 am]
BILLING CODE P
